Log in to save to my catalogue

A CD4/Foxp3/OX40 triple immunofluorescence assay determines association between T cell immune subset...

A CD4/Foxp3/OX40 triple immunofluorescence assay determines association between T cell immune subset...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4288447

A CD4/Foxp3/OX40 triple immunofluorescence assay determines association between T cell immune subsets and outcome in colorectal cancer

About this item

Full title

A CD4/Foxp3/OX40 triple immunofluorescence assay determines association between T cell immune subsets and outcome in colorectal cancer

Publisher

London: BMJ Publishing Group LTD

Journal title

Journal for immunotherapy of cancer, 2014-11, Vol.2 (S3), p.P133-P133, Article P133

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

PurposeIncreased numbers of OX40+ T cells in the tumor microenvironment of colorectal cancer (CRC) patients have been associated with improved outcome. However, the OX40+ T cell population is heterogeneous and includes, among others, CD4+Foxp3+ regulatory T cells (Treg) as well as CD4+Foxp3- effector T cells (Teff). In this study, we used a novel t...

Alternative Titles

Full title

A CD4/Foxp3/OX40 triple immunofluorescence assay determines association between T cell immune subsets and outcome in colorectal cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4288447

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4288447

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1186/2051-1426-2-S3-P133

How to access this item